公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2021 | The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer | Wu M.-F.; Lin C.-A.; Yuan T.-H.; Yeh H.-Y.; SHENG-FANG SU ; Guo C.-L.; Chang G.-C.; Li K.-C.; CHAO-CHI HO ; HUEI-WEN CHEN | Cancer Immunology, Immunotherapy | 23 | 23 | |
2016 | Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer | SHAO-LUN LU ; Feng-Ming Hsu ; KUAN-YU CHEN ; CHAO-CHI HO ; CHIH-HSIN YANG ; CHIA-HSIEN CHENG | Case Reports in Oncology | 2 | 0 | |
2011 | miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells | Lee Y.-M.; Lee J.-Y.; CHAO-CHI HO ; Hong Q.-S.; SUNG-LIANG YU ; Tzeng C.-R.; PAN-CHYR YANG ; HUEI-WEN CHEN | Breast Cancer Research | 60 | 54 | |
2021 | Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancer | CHIA-LIN HSU ; TZU-HSIU TSAI ; CHUN-KAI HUANG ; CHING-YAO YANG ; WEI-YU LIAO ; CHAO-CHI HO ; SHENG-YUAN RUAN ; KUAN-YU CHEN ; JIN-YUAN SHIH ; PAN-CHYR YANG | Lung cancer (Amsterdam, Netherlands) | 5 | 5 | |
2023 | Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitors | CHUN-TA HUANG ; Lin, Chih-An; Su, Te-Jen; CHING-YAO YANG ; TZU-HSIU TSAI ; CHIA-LIN HSU ; WEI-YU LIAO ; KUAN-YU CHEN ; CHAO-CHI HO ; CHONG-JEN YU | BMC cancer | 5 | 2 | |
2022 | Moving from tangibility toward digitalization: investigating team dynamics and facilitator support among medical students in conventional and digital small-group tutorials | CHIA-TER CHAO ; YEN-LIN CHIU ; CHIAO-LING TSAI ; MONG-WEI LIN ; CHIH-WEI YANG ; CHAO-CHI HO ; YEN-YUAN CHEN ; CHIUN HSU ; HUEY-LING CHEN | BMC medical education | 1 | 2 | |
2020 | Mucosa-associated lymphoid tissue lymphoma with isolated endobronchial involvement | TING-YU LIAO ; CHIEN-CHIN LIN ; CHANG-TSU YUAN ; CHING-KAI LIN ; CHAO-CHI HO | Respirology Case Reports | 0 | 0 | |
2013 | Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy | TZU-HSIU TSAI ; CHING-YAO YANG ; CHAO-CHI HO ; WEI-YU LIAO ; I-SHIOW JAN ; KUAN-YU CHEN ; JANN-YUAN WANG ; SHENG-YUAN RUAN ; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG ; JIN-YUAN SHIH | Lung Cancer | 33 | 30 | |
2017 | Multiple Acquired Resistance Mutations of the ALK Tyrosine Kinase Domain after Sequential Use of ALK Inhibitors | Wang H.-Y.; CHAO-CHI HO ; JIN-YUAN SHIH | Journal of Thoracic Oncology | 9 | 7 | |
2013 | Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer | WEI-YU LIAO ; Chen J.-H.; Wu M.; JIN-YUAN SHIH ; KUAN-YU CHEN ; CHAO-CHI HO ; CHIH-HSIN YANG ; CHONG-JEN YU | Clinical Lung Cancer | 22 | 20 | |
2020 | Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan | Chen Y.-M.; CHIH-HSIN YANG ; Su W.-C.; Chong I.-W.; Hsia T.-C.; Lin M.-C.; Chang G.-C.; Chiu C.-H.; CHAO-CHI HO ; Wu S.-Y.; Hung J.-Y.; Wang C.-C.; Yang T.-Y.; CHONG-JEN YU | Journal of the Formosan Medical Association | 8 | 5 | |
2013 | Non-Cytotoxic Nanomaterials Enhance Antimicrobial Activities of Cefmetazole against Multidrug-Resistant Neisseria gonorrhoeae | Li L.-H.; Yen M.-Y.; CHAO-CHI HO ; Wu P.; Wang C.-C.; Maurya P.K.; PAI-SHAN CHEN ; Chen W.; Hsieh W.-Y.; HUEI-WEN CHEN | PLoS ONE | 42 | 29 | |
2015 | Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression | ANG YUAN ; Hsiao Y.-J.; Chen H.-Y.; HUEI-WEN CHEN ; CHAO-CHI HO ; Chen Y.-Y.; Liu Y.-C.; Hong T.-H.; SUNG-LIANG YU ; Chen J.J.W.; PAN-CHYR YANG | Scientific Reports | 258 | 229 | |
2023 | Oral uracil–tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients | SHENG-KAI LIANG ; Wu, Chang-Wei; Chang, Ching-I; LI-TA KENG ; MENG-RUI LEE ; JANN-YUAN WANG ; JEN-CHUNG KO ; WEI-YU LIAO ; KUAN-YU CHEN ; CHAO-CHI HO ; JIN-YUAN SHIH ; CHONG-JEN YU | Cancer medicine | 0 | 0 | |
2018 | Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study | CHIA-CHI LIN ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHAO-CHI HO ; WEI-YU LIAO ; JIH-HSIANG LEE ; TZU-HSIU TSAI ; KANG-YI SU ; MIN-SHU HSIEH ; YIH-LEONG CHANG ; Bai Y.-Y.; DE-RUI HUANG ; Thress K.S.; CHIH-HSIN YANG | The Lancet Respiratory Medicine | 120 | 109 | |
2017 | Outcomes of cancer therapy administered to treatment-naïve lung cancer patients in the intensive care unit | YEN-FU CHEN ; JOU-WEI LIN ; CHAO-CHI HO ; CHING-YAO YANG ; CHIA-HAO CHANG ; TAO-MIN HUANG ; CHUNG-YU CHEN ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU | Journal of Cancer | 17 | 11 | |
2018 | Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors | BIN-CHI LIAO ; Bai Y.-Y; JIH-HSIANG LEE ; CHIA-CHI LIN ; SHU-YUNG LIN ; YEE-FAN LEE ; CHAO-CHI HO ; JIN-YUAN SHIH ; YEUN-CHUNG CHANG ; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG | Journal of the Formosan Medical Association | 11 | 9 | |
2024 | Patient experience with bronchoscopy: topical versus monitored anesthesia | CHUN-TA HUANG ; Chou, Rou-Jun; Hu, Geng-Ning; Lee, Tien-Cheng; Tsai, Yi-Ju; CHAO-CHI HO | BMC pulmonary medicine | | | |
2020 | Plasma-activated medium as adjuvant therapy for lung cancer with malignant pleural effusion | Cheng Y.-J.; CHING-KAI LIN ; Chen C.-Y.; Chien P.-C.; Chuan H.-H.; CHAO-CHI HO ; Cheng Y.-C. | Scientific Reports | 7 | 6 | |
2024 | Primary tumor consolidative therapy improves the outcomes of patients with advanced EGFR-mutant lung adenocarcinoma treated with first-line osimertinib | Wu, Jia-Jun; Tseng, Jeng-Sen; Zheng, Zhe-Rong; Chu, Cheng-Hsiang; Chen, Kun-Chieh; MONG-WEI LIN ; Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Yang, Tsung-Ying; SUNG-LIANG YU ; JIN-SHING CHEN ; CHAO-CHI HO ; Chang, Gee-Chen | Therapeutic advances in medical oncology | 0 | | |